Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1111 of 1,261
  1. US 7056944

    Pyrazole compositions useful as inhibitors of erk

    Vertex Pharmaceuticals Incorporated Β· Granted Jun 6, 2006 Β· Expires Jun 1, 2026

    granted
  2. US 7056734

    Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof

    The United States of America, as represented by the Department of Health and Human Services, N.I.H. Β· Granted Jun 6, 2006 Β· Expires Jun 1, 2026

    granted
  3. AU 2001289699

    New pharmaceutical composition

    CHEPLAPHARM ARZNEIMITTEL GMBH [DE] Β· Granted Jun 1, 2006 Β· Expires May 27, 2026

    expired
  4. EP 1660041

    NICHTPOLARE PHOTOSENSIBILISATOR-FORMULIERUNGEN FÜR DIE PHOTODYNAMISCHE THERAPIE

    CERAMOPTEC IND INC [US] Β· Granted May 31, 2006 Β· Expires May 26, 2026

    expired
  5. US 7052676

    Methods for inhibition of HIV replication using a small molecule inhibitor

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted May 30, 2006 Β· Expires May 25, 2026

    granted
  6. US 7053057

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated Β· Granted May 30, 2006 Β· Expires May 25, 2026

    granted
  7. US 7052832

    Methods for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. Β· Granted May 30, 2006 Β· Expires May 25, 2026

    granted
  8. US 7052674

    Prokineticin polypeptides, related compositions and methods

    The Regents of the University of California Β· Granted May 30, 2006 Β· Expires May 25, 2026

    granted
  9. US 7053125

    Controlled dispersion of colloidal suspension by comb polymers

    W.R. Grace & Co.-Conn. Β· Granted May 30, 2006 Β· Expires May 25, 2026

    granted
  10. US 7053119

    Methods for identifying and using IKK inhibitors

    The Regents of the University of California Β· Granted May 30, 2006 Β· Expires May 25, 2026

    granted
  11. US 7053243

    3-Methoxybenzyl thiourea derivatives and improved lipid compositions containing same

    The United States of America, as represented by the Secretary of Agriculture Β· Granted May 30, 2006 Β· Expires May 25, 2026

    granted
  12. US 7053263

    Mouse models of human prostate cancer progression

    The Regents of the University of California Β· Granted May 30, 2006 Β· Expires May 25, 2026

    granted
  13. US 7052829

    Prevascularized constructs for implantation to provide blood perfusion

    Arizona Board of Regents on Behalf of the University of Arizona Β· Granted May 30, 2006 Β· Expires May 25, 2026

    granted
  14. US 7052703

    T-cell receptorΞ³ alternate reading frame protein, (TARP) and uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted May 30, 2006 Β· Expires May 25, 2026

    granted
  15. US 7052696

    Antigenic epitopes and mosaic polypeptides of hepatitis C virus proteins

    The United States of America, as represented by the Department of Health and Human Services Β· Granted May 30, 2006 Β· Expires May 25, 2026

    granted
  16. US 7052705

    Anti-angiogenic peptides

    REGENERON PHARMACEUTICALS, INC. Β· Granted May 30, 2006 Β· Expires May 25, 2026

    granted
  17. US 7052695

    Angiopoietins and methods of treating hypertension

    REGENERON PHARMACEUTICALS, INC. Β· Granted May 30, 2006 Β· Expires May 25, 2026

    granted
  18. US 7052691

    Methods of treating diabetes by blocking VEGF-mediated activity

    REGENERON PHARMACEUTICALS, INC. Β· Granted May 30, 2006 Β· Expires May 25, 2026

    granted
  19. US 7053150

    Segmented polymers and their conjugates

    Nektar Therapeutics AL, Corporation Β· Granted May 30, 2006 Β· Expires May 25, 2026

    granted
  20. US 7052907

    Adult human dental pulp stem cells in vitro and in vivo

    The United States of America, as represented by the Department of Health and Human Services Β· Granted May 30, 2006 Β· Expires May 25, 2026

    granted
  21. US 7053053

    Humanin-like peptide and use thereof

    Takeda Chemical Industries Ltd. Β· Granted May 30, 2006 Β· Expires May 25, 2026

    granted
  22. US 7052904

    Hybrid adeno-retroviral vector for the transfection of cells

    The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted May 30, 2006 Β· Expires May 25, 2026

    granted
  23. US 7052890

    Transglutaminase gene products

    University College Cardiff Consultants Limited Β· Granted May 30, 2006 Β· Expires May 25, 2026

    granted
  24. US 7052856

    NELL-1 enhanced bone mineralization

    The Regents of the University of California Β· Granted May 30, 2006 Β· Expires May 25, 2026

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.